Neuronal ceroïdlipofuscinose

The group of disorders known as the neuronal ceroid lipofuscinoses have common features including a variable age of onset, motor and mental decline, epilepsy, and visual loss. Common symptoms together with the presence of abnormal lysosomal storage in neurons and other cells define the condition.  Collectively the NCLs are important as one of the causes of childhood neurodegenerative diseases. Based on the clinical presentations different types have been described in the medical literature, such as the late infantile NCL type 2, Jansky–Bielschowsky disease and the juvenile NCL type 3 Batten disease.  Most NCLs are autosomal recessively inherited. Mutations in at least eight genes (PPT1/CLN1, TPP1/CLN2, CLN3, CLN5, CLN6, MFSD8/CLN7, CLN8) have been identified. The prevalence around 0.5–8 per 100,000 live births varying per region.

Last modified
4 August 2020
Abbreviation
NCL
ORPHA

Orpha: 216 Neuronal ceroïdlipofuscinose

Disease
Symptom
A sudden changes in movements, behaviour or feelings, in levels of consciousness can be seizure, caused by uncontrolled electrical disturbance in the brain. There are...
Social Support